Outcomes of reintroducing anti-tuberculosis drugs following cutaneous adverse drug reactions-Reference-Cited by-同舟云学术

Outcomes of reintroducing anti-tuberculosis drugs following cutaneous adverse drug reactions

Published:2011-12-01 Issue:12 Volume:15 Page:1649-1657
ISSN:1027-3719
Container-title:The International Journal of Tuberculosis and Lung Disease
language:en
Short-container-title:int j tuberc lung dis

Author:

Lehloenya R.J.¹,Todd G.²,Badri M.³,Dheda K.⁴

Affiliation:

1. Division of Dermatology, Department of Medicine, University of Cape Town, Cape Town, South Africa; Lung Infection and Immunity Unit, Division of Pulmonology & University of Cape Town Lung Institute, Department of Medicine, University of Cape Town, Cape Town, South Africa

2. Division of Dermatology, Department of Medicine, University of Cape Town, Cape Town, South Africa

3. Department of Medicine, University of Cape Town, Cape Town, South Africa; College of Medicine, King Saud Bin Abadulaziz University for Health Sciences, Riyadh, Saudi Arabia

4. Lung Infection and Immunity Unit, Division of Pulmonology & University of Cape Town Lung Institute, Department of Medicine, University of Cape Town, Cape Town, South Africa; Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa

Publisher

International Union Against Tuberculosis and Lung Disease

Subject

Infectious Diseases,Pulmonary and Respiratory Medicine

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-Line Antituberculosis Drug Challenge Reactions in Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome in an HIV Endemic Setting;The Journal of Allergy and Clinical Immunology: In Practice;2024-06

2. Hypersensitivity reactions with first-line antituberculosis drugs and outcomes of rapid desensitizations;World Allergy Organization Journal;2024-01

3. Ethical considerations in the management of drug severe cutaneous adverse reactions;Journal of the American Academy of Dermatology;2024-01

4. Long-term HIV and tuberculosis outcomes in patients hospitalised with severe cutaneous adverse reactions;Journal of Clinical Tuberculosis and Other Mycobacterial Diseases;2023-08

5. Skin Testing and Drug Provocation Tests in Epidermal Necrolysis: A French Experience;The Journal of Allergy and Clinical Immunology: In Practice;2022-12